These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 28422306)

  • 1. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Lai JC; Covinsky KE; Dodge JL; Boscardin WJ; Segev DL; Roberts JP; Feng S
    Hepatology; 2017 Aug; 66(2):564-574. PubMed ID: 28422306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis.
    Lai JC; Covinsky KE; McCulloch CE; Feng S
    Am J Gastroenterol; 2018 Feb; 113(2):235-242. PubMed ID: 29231189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Kardashian A; Ge J; McCulloch CE; Kappus MR; Dunn MA; Duarte-Rojo A; Volk ML; Rahimi RS; Verna EC; Ganger DR; Ladner D; Dodge JL; Boyarsky B; McAdams-DeMarco M; Segev DL; Lai JC
    Hepatology; 2021 Mar; 73(3):1132-1139. PubMed ID: 32491208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers and physical frailty in patients with end-stage liver disease.
    Kuo SZ; Lizaola B; Hayssen H; Lai JC
    World J Gastroenterol; 2018 Sep; 24(33):3770-3775. PubMed ID: 30197482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Range and Reproducibility of the Liver Frailty Index.
    Wang CW; Lebsack A; Chau S; Lai JC
    Liver Transpl; 2019 Jun; 25(6):841-847. PubMed ID: 30884128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in frailty are associated with waitlist mortality in patients with cirrhosis.
    Lai JC; Dodge JL; Kappus MR; Dunn MA; Volk ML; Duarte-Rojo A; Ganger DR; Rahimi RS; McCulloch CE; Haugen CE; McAdams-DeMarco M; Ladner DP; Segev DL; Verna EC;
    J Hepatol; 2020 Sep; 73(3):575-581. PubMed ID: 32240717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Study of Age, Frailty, and Waitlist Mortality Among Liver Transplant Candidates.
    Haugen CE; McAdams-DeMarco M; Holscher CM; Ying H; Gurakar AO; Garonzik-Wang J; Cameron AM; Segev DL; Lai JC
    Ann Surg; 2020 Jun; 271(6):1132-1136. PubMed ID: 30672803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.
    Kim JJ; Kim JH; Koo JK; Choi YJ; Ko SY; Choe WH; Kwon SY
    Clin Mol Hepatol; 2014 Mar; 20(1):47-55. PubMed ID: 24757658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frailty predicts waitlist mortality in liver transplant candidates.
    Lai JC; Feng S; Terrault NA; Lizaola B; Hayssen H; Covinsky K
    Am J Transplant; 2014 Aug; 14(8):1870-9. PubMed ID: 24935609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
    Li JY; Deng Q; Wang Y; Xu MY; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
    Lai JC; Ganger DR; Volk ML; Dodge JL; Dunn MA; Duarte-Rojo A; Kappus MR; Rahimi RS; Ladner DP; Boyarsky B; McAdams-DeMarco M; Segev DL; McCulloch CE; Verna EC
    JAMA Surg; 2021 Mar; 156(3):256-262. PubMed ID: 33377947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically relevant cut-points for changes in the Liver Frailty Index are associated with waitlist mortality in patients with cirrhosis.
    Wang M; Shui AM; Ruck J; Huang CY; Verna EC; King EA; Ladner DP; Ganger D; Kappus M; Rahimi R; Tevar AD; Duarte-Rojo A; Lai JC
    Liver Transpl; 2024 Oct; 30(10):991-1001. PubMed ID: 38900010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
    Samoylova ML; Covinsky KE; Haftek M; Kuo S; Roberts JP; Lai JC
    Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of MELD3.0 in 2 centers from different continents.
    Tejedor M; Bellón JM; Fernández de la Varga M; Peralta P; Montalvá E; Selzner N; Berenguer M
    Hepatol Commun; 2024 Aug; 8(8):. PubMed ID: 39082971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study.
    Lai JC; Dodge JL; Sen S; Covinsky K; Feng S
    Hepatology; 2016 Feb; 63(2):574-80. PubMed ID: 26517301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP; Tandon P; Ney M; Meeberg G; Faris P; Shaheen AA; Aspinall AI; Burak KW
    Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.
    Reddy KR; O'Leary JG; Kamath PS; Fallon MB; Biggins SW; Wong F; Patton HM; Garcia-Tsao G; Subramanian RM; Thacker LR; Bajaj JS;
    Liver Transpl; 2015 Jul; 21(7):881-8. PubMed ID: 25845966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.